194 related articles for article (PubMed ID: 12093082)
21. The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module.
Garcia M; Vanhoutte P; Pages C; Besson MJ; Brouillet E; Caboche J
J Neurosci; 2002 Mar; 22(6):2174-84. PubMed ID: 11896157
[TBL] [Abstract][Full Text] [Related]
22. Cyclosporin A protects striatal neurons in vitro and in vivo from 3-nitropropionic acid toxicity.
Leventhal L; Sortwell CE; Hanbury R; Collier TJ; Kordower JH; Palfi S
J Comp Neurol; 2000 Oct; 425(4):471-8. PubMed ID: 10975874
[TBL] [Abstract][Full Text] [Related]
23. Differential localization of the GluR1 and GluR2 subunits of the AMPA-type glutamate receptor among striatal neuron types in rats.
Deng YP; Xie JP; Wang HB; Lei WL; Chen Q; Reiner A
J Chem Neuroanat; 2007 Jul; 33(4):167-92. PubMed ID: 17446041
[TBL] [Abstract][Full Text] [Related]
24. Participation of par-4 in the degeneration of striatal neurons induced by metabolic compromise with 3-nitropropionic acid.
Duan W; Guo Z; Mattson MP
Exp Neurol; 2000 Sep; 165(1):1-11. PubMed ID: 10964480
[TBL] [Abstract][Full Text] [Related]
25. Granulocyte-colony stimulating factor attenuates striatal degeneration with activating survival pathways in 3-nitropropionic acid model of Huntington's disease.
Lee ST; Park JE; Kim DH; Kim S; Im WS; Kang L; Jung SH; Kim MW; Chu K; Kim M
Brain Res; 2008 Feb; 1194():130-7. PubMed ID: 18166168
[TBL] [Abstract][Full Text] [Related]
26. Systemic 3-nitropropionic acid: behavioral deficits and striatal damage in adult rats.
Borlongan CV; Koutouzis TK; Randall TS; Freeman TB; Cahill DW; Sanberg PR
Brain Res Bull; 1995; 36(6):549-56. PubMed ID: 7538873
[TBL] [Abstract][Full Text] [Related]
27. Memantine reduces striatal cell death with decreasing calpain level in 3-nitropropionic model of Huntington's disease.
Lee ST; Chu K; Park JE; Kang L; Ko SY; Jung KH; Kim M
Brain Res; 2006 Nov; 1118(1):199-207. PubMed ID: 16959224
[TBL] [Abstract][Full Text] [Related]
28. Melatonin reduces projection neuronal injury induced by 3-nitropropionic acid in the rat striatum.
Mu S; Lin E; Liu B; Ma Y; OuYang L; Li Y; Chen S; Zhang J; Lei W
Neurodegener Dis; 2014; 14(3):139-50. PubMed ID: 25342207
[TBL] [Abstract][Full Text] [Related]
29. Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.
Reynolds DS; Carter RJ; Morton AJ
J Neurosci; 1998 Dec; 18(23):10116-27. PubMed ID: 9822765
[TBL] [Abstract][Full Text] [Related]
30. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat.
Brouillet E; Guyot MC; Mittoux V; Altairac S; Condé F; Palfi S; Hantraye P
J Neurochem; 1998 Feb; 70(2):794-805. PubMed ID: 9453576
[TBL] [Abstract][Full Text] [Related]
31. The vulnerability of striatal projection neurons and interneurons to excitotoxicity is differentially regulated by dopamine during development.
Pezzi S; Checa N; Alberch J
Int J Dev Neurosci; 2005 Jun; 23(4):343-9. PubMed ID: 15927758
[TBL] [Abstract][Full Text] [Related]
32. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
Hughes PE; Alexi T; Williams CE; Clark RG; Gluckman PD
Neuroscience; 1999; 92(1):197-209. PubMed ID: 10392842
[TBL] [Abstract][Full Text] [Related]
33. Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats.
Périer C; Marin C; Jimenez A; Bonastre M; Tolosa E; Hirsch EC
J Neurochem; 2003 Sep; 86(6):1328-37. PubMed ID: 12950442
[TBL] [Abstract][Full Text] [Related]
34. Striatal parvalbuminergic neurons are lost in Huntington's disease: implications for dystonia.
Reiner A; Shelby E; Wang H; Demarch Z; Deng Y; Guley NH; Hogg V; Roxburgh R; Tippett LJ; Waldvogel HJ; Faull RL
Mov Disord; 2013 Oct; 28(12):1691-9. PubMed ID: 24014043
[TBL] [Abstract][Full Text] [Related]
35. Enkephalinergic striatal projection neurons become less affected by quinolinic acid than substance P-containing striatal projection neurons as rats age.
Sun Z; Chen Q; Reiner A
Exp Neurol; 2003 Dec; 184(2):1034-42. PubMed ID: 14769398
[TBL] [Abstract][Full Text] [Related]
36. Transneuronal degeneration in substantia nigra pars reticulata following striatal excitotoxic injury in adult rat: time-course, distribution, and morphology of cell death.
Stefanis L; Burke RE
Neuroscience; 1996 Oct; 74(4):997-1008. PubMed ID: 8895868
[TBL] [Abstract][Full Text] [Related]
37. Neurturin protects striatal projection neurons but not interneurons in a rat model of Huntington's disease.
Pérez-Navarro E; Akerud P; Marco S; Canals JM; Tolosa E; Arenas E; Alberch J
Neuroscience; 2000; 98(1):89-96. PubMed ID: 10858615
[TBL] [Abstract][Full Text] [Related]
38. Effects of systemic 3-nitropropionic acid-induced lesions of the dorsal striatum on cannabinoid and mu-opioid receptor binding in the basal ganglia.
Page KJ; Besret L; Jain M; Monaghan EM; Dunnett SB; Everitt BJ
Exp Brain Res; 2000 Jan; 130(2):142-50. PubMed ID: 10672467
[TBL] [Abstract][Full Text] [Related]
39. Selective loss of striatal preprotachykinin neurons in a phenocopy of Huntington's disease.
Richfield EK; Vonsattel JP; MacDonald ME; Sun Z; Deng YP; Reiner A
Mov Disord; 2002 Mar; 17(2):327-32. PubMed ID: 11921119
[TBL] [Abstract][Full Text] [Related]
40. Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.
Mehler MF; Petronglo JR; Arteaga-Bracho EE; Gulinello ME; Winchester ML; Pichamoorthy N; Young SK; DeJesus CD; Ishtiaq H; Gokhan S; Molero AE
J Neurosci; 2019 Mar; 39(10):1892-1909. PubMed ID: 30626701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
